Advertisement
Screener

Gartner, Inc. (IT) Derivative Instruments, Gain (Loss) Recognized in Income, Net (Deprecated 2013-01-31)

3.2 / 5 stars · 76/120 Roast Me

Gartner, Inc. Derivative Instruments, Gain (Loss) Recognized in Income, Net (Deprecated 2013-01-31)

Gartner, Inc. (IT) reported Derivative Instruments, Gain (Loss) Recognized in Income, Net (Deprecated 2013-01-31) of $4.10 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-26.

Discontinued › Income Statement › Other Income

us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet · last filed 2014-02-26

  • Gartner, Inc. derivative instruments, gain (loss) recognized in income, net (deprecated 2013-01-31) for the quarter ending 2013-12-31 was -$3.11M.
  • Gartner, Inc. derivative instruments, gain (loss) recognized in income, net (deprecated 2013-01-31) for the quarter ending 2013-09-30 was $1.01M, a 7.53% increase year-over-year.
  • Gartner, Inc. derivative instruments, gain (loss) recognized in income, net (deprecated 2013-01-31) for the quarter ending 2013-06-30 was $1.09M, a 98.73% increase year-over-year.
  • Gartner, Inc. derivative instruments, gain (loss) recognized in income, net (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $1.01M, a 68.55% increase year-over-year.
  • Gartner, Inc. derivative instruments, gain (loss) recognized in income, net (deprecated 2013-01-31) for fiscal 2013 was $4.10K, a 36.67% increase from fiscal 2012.
  • Gartner, Inc. derivative instruments, gain (loss) recognized in income, net (deprecated 2013-01-31) for fiscal 2012 was $3.00K, a 43.40% decline from fiscal 2011.
  • Gartner, Inc. derivative instruments, gain (loss) recognized in income, net (deprecated 2013-01-31) for fiscal 2011 was $5.30K, a 32.91% decline from fiscal 2010.
  • Gartner, Inc. derivative instruments, gain (loss) recognized in income, net (deprecated 2013-01-31) for fiscal 2010 was $7.90K, a 11.24% decline from fiscal 2009.
Period endDerivative Instruments, Gain (Loss) Recognized in Income, Net (Deprecated 2013-01-31) 3 monthDerivative Instruments, Gain (Loss) Recognized in Income, Net (Deprecated 2013-01-31) 6 monthDerivative Instruments, Gain (Loss) Recognized in Income, Net (Deprecated 2013-01-31) 9 monthDerivative Instruments, Gain (Loss) Recognized in Income, Net (Deprecated 2013-01-31) 12 month
2013-12-31-$3.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
-$2.10M
derived: sum of 2 quarters · filed 2014-02-26
-$1.01M
derived: sum of 3 quarters · filed 2014-02-26
$4.10K
10-K · filed 2014-02-26
2013-09-30$1.01M
10-Q · filed 2013-11-07
$2.11M
derived: sum of 2 quarters · filed 2013-11-07
$3.12M
10-Q · filed 2013-11-07
$1.03M
derived: sum of 4 quarters · filed 2014-02-26
2013-06-30$1.09M
10-Q · filed 2013-08-02
$2.10M
10-Q · filed 2013-08-02
$15.00K
derived: sum of 3 quarters · filed 2014-02-26
$958.00K
derived: sum of 4 quarters · filed 2014-02-26
2013-03-31$1.01M
10-Q · filed 2013-05-02
-$1.08M
derived: sum of 2 quarters · filed 2014-02-26
-$135.00K
derived: sum of 3 quarters · filed 2014-02-26
$415.00K
derived: sum of 4 quarters · filed 2014-02-26
2012-12-31-$2.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
-$1.15M
derived: sum of 2 quarters · filed 2014-02-26
-$598.00K
derived: sum of 3 quarters · filed 2014-02-26
$3.00K
10-K · filed 2014-02-26
2012-09-30$943.00K
10-Q · filed 2013-11-07
$1.49M
derived: sum of 2 quarters · filed 2013-11-07
$2.09M
10-Q · filed 2013-11-07
-$2.79M
derived: sum of 4 quarters · filed 2014-02-26
2012-06-30$550.00K
10-Q · filed 2013-08-02
$1.15M
10-Q · filed 2013-08-02
-$3.74M
derived: sum of 3 quarters · filed 2014-02-26
-$4.69M
derived: sum of 4 quarters · filed 2014-02-26
2012-03-31$601.00K
10-Q · filed 2013-05-02
-$4.29M
derived: sum of 2 quarters · filed 2014-02-26
-$5.24M
derived: sum of 3 quarters · filed 2014-02-26
-$3.53M
derived: sum of 4 quarters · filed 2014-02-26
2011-12-31-$4.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
-$5.84M
derived: sum of 2 quarters · filed 2014-02-26
-$4.13M
derived: sum of 3 quarters · filed 2014-02-26
$5.30K
10-K · filed 2014-02-26
2011-09-30-$954.00K
10-Q · filed 2012-11-06
$762.00K
derived: sum of 2 quarters · filed 2012-11-06
$4.89M
10-Q · filed 2012-11-06
$197.90K
derived: sum of 4 quarters · filed 2013-02-22
2011-06-30$1.72M
10-Q · filed 2012-08-03
$5.85M
10-Q · filed 2012-08-03
$1.15M
derived: sum of 3 quarters · filed 2013-02-22
$4.45M
derived: sum of 4 quarters · filed 2013-02-22
2011-03-31$4.13M
10-Q · filed 2012-05-03
-$564.10K
derived: sum of 2 quarters · filed 2013-02-22
$2.73M
derived: sum of 3 quarters · filed 2013-02-22
$2.42M
derived: sum of 4 quarters · filed 2013-02-22
2010-12-31-$4.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
-$1.40M
derived: sum of 2 quarters · filed 2013-02-22
-$1.71M
derived: sum of 3 quarters · filed 2013-02-22
$7.90K
10-K · filed 2013-02-22
2010-09-30$3.30M
10-Q · filed 2011-11-01
$2.99M
derived: sum of 2 quarters · filed 2011-11-01
$4.70M
10-Q · filed 2011-11-01
2010-06-30-$309.00K
10-Q · filed 2011-08-02
$1.41M
10-Q · filed 2011-08-02
2009-12-31$8.90K
10-K · filed 2012-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Evolent Health, Inc. (EVH)United States$0.397B-1.21
FRANKLIN COVEY CO (FC)United States$0.195B123.76